Medeonföretag

Ascelia Pharma

Ascelia is an oncology-dedicated drug development company focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. Ascelia´s strategy is to develop and make available to patients a portfolio of differentiated, underappreciated and de-risked product candidates addressing unmet medical needs in cancer and cancer-related diseases. Ascelia is fully focused on two clinical-stage product candidates under development: Mangoral and Oncoral.

ADRESS
Ascelia Pharma AB
St. Johannesgatan 2
211 46 Malmö
SWEDEN

KONTAKT
Magnus Corfitzen, Chief Executive officer
Telefon: +46 735 179 110
E-post: moc@ascelia.com

Webbsida: http://www.ascelia.com

Medeon är en viktig life science-nod med sin centrala placering och specifika nätverk som erbjuder en av Öresundsregionens bästa tillväxtmiljöer för företagande och främjar utbytet mellan akademi, det offentliga och näringslivet.

Catrine Pauckstadt
Communications Manager